In vitro studies, animal models, and clinical trials suggest that the up-regulation of the Nrf2 pathway can be protective against DM (T1 and T2) by suppressing the disease progression and preventing complications [32,47,48,49]. The gene discussed is NFE2L2; the disease is diabetes mellitus.